SIFRIM-HITZ-WEISS SYNDROME
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Multiple congenital anomalies
|
0.100 |
CausalMutation
|
group |
CLINVAR |
Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing.
|
27479907 |
2016 |
Multiple congenital anomalies
|
0.100 |
CausalMutation
|
group |
CLINVAR |
Regulation of DNA-damage responses and cell-cycle progression by the chromatin remodelling factor CHD4.
|
20693977 |
2010 |
Multiple congenital anomalies
|
0.100 |
CausalMutation
|
group |
CLINVAR |
The NuRD chromatin-remodeling enzyme CHD4 promotes embryonic vascular integrity by transcriptionally regulating extracellular matrix proteolysis.
|
24348274 |
2013 |
Multiple congenital anomalies
|
0.100 |
CausalMutation
|
group |
CLINVAR |
De Novo Mutations in CHD4, an ATP-Dependent Chromatin Remodeler Gene, Cause an Intellectual Disability Syndrome with Distinctive Dysmorphisms.
|
27616479 |
2016 |
Multiple congenital anomalies
|
0.100 |
CausalMutation
|
group |
CLINVAR |
Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database.
|
25849321 |
2016 |
Multiple congenital anomalies
|
0.100 |
CausalMutation
|
group |
CLINVAR |
Constraint of gene expression by the chromatin remodelling protein CHD4 facilitates lineage specification.
|
26116663 |
2015 |
Multiple congenital anomalies
|
0.100 |
CausalMutation
|
group |
CLINVAR |
Chromatin remodeling inactivates activity genes and regulates neural coding.
|
27418512 |
2016 |
Multiple congenital anomalies
|
0.100 |
CausalMutation
|
group |
CLINVAR |
Prevalence and architecture of de novo mutations in developmental disorders.
|
28135719 |
2017 |
Multiple congenital anomalies
|
0.100 |
CausalMutation
|
group |
CLINVAR |
The nucleosome remodeling and deacetylase chromatin remodeling (NuRD) complex is required for peripheral nerve myelination.
|
22302795 |
2012 |
Dysmorphic features
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
De Novo Mutations in CHD4, an ATP-Dependent Chromatin Remodeler Gene, Cause an Intellectual Disability Syndrome with Distinctive Dysmorphisms.
|
27616479 |
2016 |
Dysmorphic features
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Chromatin remodeling inactivates activity genes and regulates neural coding.
|
27418512 |
2016 |
Dysmorphic features
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Prevalence and architecture of de novo mutations in developmental disorders.
|
28135719 |
2017 |
Dysmorphic features
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
The NuRD chromatin-remodeling enzyme CHD4 promotes embryonic vascular integrity by transcriptionally regulating extracellular matrix proteolysis.
|
24348274 |
2013 |
Dysmorphic features
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
The nucleosome remodeling and deacetylase chromatin remodeling (NuRD) complex is required for peripheral nerve myelination.
|
22302795 |
2012 |
Dysmorphic features
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database.
|
25849321 |
2016 |
Dysmorphic features
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Constraint of gene expression by the chromatin remodelling protein CHD4 facilitates lineage specification.
|
26116663 |
2015 |
Dysmorphic features
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing.
|
27479907 |
2016 |
Dysmorphic features
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Regulation of DNA-damage responses and cell-cycle progression by the chromatin remodelling factor CHD4.
|
20693977 |
2010 |
Malignant Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
Based on The Cancer Genome Atlas and Rembrandt datasets, CHD4 expression is associated with poor prognosis in patients.
|
30872624 |
2019 |
Malignant Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
We find that CHD4 depletion induces up-regulation of the cancer stem cell (CSC) marker CD133.
|
29888111 |
2018 |
Primary malignant neoplasm
|
0.070 |
AlteredExpression
|
group |
BEFREE |
Based on The Cancer Genome Atlas and Rembrandt datasets, CHD4 expression is associated with poor prognosis in patients.
|
30872624 |
2019 |
Primary malignant neoplasm
|
0.070 |
AlteredExpression
|
group |
BEFREE |
We find that CHD4 depletion induces up-regulation of the cancer stem cell (CSC) marker CD133.
|
29888111 |
2018 |
Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
A high expression of CHD4 was significantly associated with pre-treatment tumor status (<i>p</i> < 0.001) and lymph node metastasis (<i>p</i> < 0.001), post-treatment tumor status (<i>p</i> < 0.001), and lymph node metastasis (<i>p</i> < 0.001), vascular invasion (<i>p</i> = 0.042), and tumor regression grade (<i>p</i> = 0.001).
|
31438571 |
2019 |
Adult Glioblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma.
|
30872624 |
2019 |